On June 3, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) announced the initiation of dosing in an investigational Phase 1b clinical trial of APD334, a novel, oral drug candidate that targets the sphingosine 1-phosphate subtype 1 (S1P1) receptor, to evaluate the compound for the treatment of a number of autoimmune diseases. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock opened today at $6.19 and is currently trading at $6.12. The stock showed a negative weekly performance of -1.76%.
On June 4, Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) the leader in antisense therapeutics, announced that management will present a company overview at the Goldman Sachs 35th Annual Global Healthcare Conference on Wednesday, June 11, 2014 at 8:40 a.m. PT in Rancho Palos Verdes, CA. ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) stock opened at $30.58, in current trading session and currently is at $30.02, by losing -0.78%. The 52 week range of the stock is $20.52 – $62.66. Company’s market capitalization is $ 3.54 billion.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) on June 2 announced longer-term follow up from its Phase 1 and pivotal Phase 2 trials of Iclusig® (ponatinib), its approved BCR-ABL inhibitor, in heavily pretreated patients with resistant or intolerant chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock is currently trading at $6.73. The EPS of the stock is -1.40. Company’s market capitalization is $1.25 billion.
Illumina, Inc. (NASDAQ:ILMN) is offering convertible senior notes amounting to $900 million. Such notes will help it earn good amount of money, which can be used for repaying the previous notes that are due soon. Illumina, Inc. (NASDAQ:ILMN) stock opened the session at $ 166.45, and now is at $166.29. The 52 week range of the stock remained $66.11 – $183.30 and the day range was $163.11 – $166.95.
On June 2, Celgene (NASDAQ:CELG) was downgraded by JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating in a research note issued on Thursday, TheFlyOnTheWall.comreports. Celgene Corporation (NASDAQ:CELG) stock opened today at $162.99 and is currently trading at $161.09. The stock showed a positive weekly performance of 5.52%.
Leave a Reply